NTSR1 and neoplasm: Due to its nanomolar NTSR1 affinity, the simple and high-yielding radiosynthesis using the HYNIC precursor 5, and the excellent tumor uptake in vivo (8.8 ± 3.4 %ID/g at 2 h p.i.), we suggest [99mTc]1 as a candidate for clinical translation.